Rate this Article: Comparative Study of Additive IOP Lowering Effects and Safety Profile of Ripasudil 0.4% Combined with Timolol 0.5% and Ripasudil 0.4% Combined with Bimatoprost 0.03% In Primary Open Angle Glaucoma in Indian Eyes

Rating (1-10):

1

Comments (SR231206212100):

Please enter 100–200 characters. 0/200 characters

Full Name: Email Address (Important: You will receive Rating Verification Link on this Email Address):

Leave this field empty

Back to Article